Fueling health policy solutions through scholarship and science.

  • Policy Brief • 06/02/23

    Alzheimer’s Disease Monoclonal Antibodies with Traditional Approval: Clarifying the Pathway for Medi...

    Read the Paper
  • News • 06/02/23

    The Future of Public Health: Public Health 3.0 and Accountable Population Health

    Read the Paper
  • Press Release • 06/02/23

    Opioid Abatement Needs and Investment Tool

    Read the Press Release
  • Policy Brief • 06/02/23

    Community Health Workers Key to Advancing Health Equity

    Read the Paper
  • Event • 06/02/23

    Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches

    Register Now!

Focus Area

Cross-Cutting Themes


Stay current on the latest from Duke-Margolis Center by subscribing to our newsletters.

Duke-Margolis Spotlight

A Conversation with U.S. Senator Todd Young: Addressing the Threat of Drug Resistant Infections


Effective antimicrobials treat a range of infections and enable clinicians to provide care that might otherwise result in dangerous infections.


Unfortunately, the development and spread of antimicrobial resistance (AMR) and drug-resistant infections poses a severe and growing threat to us all.


To address this threat, policymakers are carefully considering how to meet immediate and future demand for novel antimicrobials with thoughtful market incentives under challenging circumstances.


Thank you for your interest in making a gift to the Duke-Margolis Center for Health Policy.